Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Undergoing TAVR and mitral valve interventions during a single hospital visit may put patients at risk

The risk of in-hospital mortality, for instance, increased considerably when patients underwent TAVR and a mitral procedure. 

Thumbnail

AI model predicts diabetes risk using MRI results

The algorithm measures the amount of fat surrounding a person's heart, using that information to create an accurate diabetes risk assessment. 

Thumbnail

The surprising relationship between congenital heart disease and stroke

The new analysis, published in the Journal of the American Heart Association, examines the connection between CHD and stroke risk from multiple angles. 

Thumbnail

TAVR safe for patients with inflammatory bowel disease

Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm

Cardiologist makes history, completes LAAO with new 3D ICE catheter

An interventional cardiologist at Mayo Clinic in Rochester, Minnesota, carried out the procedure. 

Thumbnail

Risk score predicts outcomes for heart failure patients undergoing TEER

The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period. 

Thumbnail

Minnesota cardiologist first in world to complete structural heart procedure with 4D holograms

"We are always looking for new ways to advance and improve patient care, and are proud to be the first center in the world to offer this novel imaging technology,” the specialist said.